Kidney Res Clin Pract.
2023 Mar;42(2):275-278. 10.23876/j.krcp.22.194.
Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease
- Affiliations
-
- 1Department of Nephrology, Saint-Luc University Clinics, Brussels, Belgium
- 2Department of Microbiology, Saint-Luc University Clinics, Brussels, Belgium
- 3Department of Pharmacy, Saint-Luc University Clinics, Brussels, Belgium
- 4Department of Internal Medicine and Infectious Disease, Saint-Luc University Clinics, Brussels, Belgium
- KMID: 2543781
- DOI: http://doi.org/10.23876/j.krcp.22.194
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Determining and Comparing the RealWorld Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19
- Effectiveness of Molnupiravir Treatment in Patients with COVID-19 in Korea: A Propensity Score Matched Study
- The coronavirus disease 2019 pandemic and chronic diseases
- Effectiveness and Adverse Events of Nirmatrelvir/Ritonavir Versus Molnupiravir for COVID-19 in Outpatient Setting: Multicenter Prospective Observational Study
- The Management of Thyroid Disease in COVID-19 Pandemic
